HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pauline T Merrill Selected Research

Pauline T Merrill Research Topics

Disease

9Uveitis
10/2023 - 04/2012
5Macular Edema
10/2023 - 04/2019
5Panuveitis
11/2021 - 01/2016
4Inflammation (Inflammations)
10/2020 - 09/2016
2Posterior Uveitis
01/2021 - 12/2018
2Intermediate Uveitis (Chronic Cyclitis)
01/2021 - 12/2018
2Tuberculosis (Tuberculoses)
01/2016 - 01/2012
1Retinal Vasculitis
09/2022
1Cicatrix (Scar)
11/2021
1Retinal Detachment (Retinal Detachments)
11/2021
1Retinal Perforations
11/2021
1Immunoglobulin G4-Related Disease
04/2019
1Edema (Dropsy)
04/2019
1Headache (Headaches)
09/2016
1Arthralgia (Joint Pain)
09/2016
1Neoplasms (Cancer)
09/2016
1Nasopharyngitis
09/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2016
1Cataract (Cataracts)
04/2016
1Syphilis
01/2016
1Birdshot Chorioretinopathy
01/2016
1Central Serous Chorioretinopathy
01/2012
1Acute Retinal Necrosis Syndrome
01/2010
1Iritis
01/2010

Drug/Important Bio-Agent (IBA)

6SteroidsIBA
10/2023 - 01/2010
5Adrenal Cortex Hormones (Corticosteroids)IBA
10/2023 - 09/2016
4Fluocinolone Acetonide (Capex)FDA LinkGeneric
10/2023 - 04/2016
3Adalimumab (Humira)FDA Link
11/2021 - 09/2016
3Sirolimus (Rapamycin)FDA Link
10/2020 - 11/2016
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
10/2023 - 01/2010
2Triamcinolone (Aristocort)FDA Link
04/2019 - 01/2010
1SuspensionsIBA
10/2023
1Methotrexate (Mexate)FDA LinkGeneric
09/2022
1perflutren (octafluoropropane)FDA Link
11/2021
1HLA-B27 Antigen (HLA B27 Antigen)IBA
09/2019
1Rituximab (Mabthera)FDA Link
04/2019
1TOR Serine-Threonine KinasesIBA
12/2018
1Prednisone (Sone)FDA LinkGeneric
09/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2016
1Immunologic Factors (Immunomodulators)IBA
09/2016
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2016
1Retinaldehyde (Retinal)IBA
01/2016
1HLA-A29 antigenIBA
01/2016
1Rifampin (Rifampicin)FDA LinkGeneric
01/2012

Therapy/Procedure

2Therapeutics
10/2023 - 01/2012
2Vitrectomy
11/2021 - 04/2012
1Aftercare (After-Treatment)
04/2019
1Immunomodulation
12/2018